Literature DB >> 2962666

Measurement of prostaglandins, thromboxanes and hydroxy fatty acids by stable isotope dilution gas chromatography/mass spectrometry.

H J Leis1, E Hohenester, H Gleispach, E Malle, B Mayer.   

Abstract

A method for measurement of PGF2 alpha, PGE1, PGE2, 6-keto-PGF1 alpha, TXB2, 2,3-dinor-TXB2 as well as 5-, 8-, 9-, 11-, 12-, 15-HETE and HHT, utilizing negative ion chemical ionization GC/MS is presented. A highly efficient separation and purification procedure prior to the derivatization sequence allows quantification of the arachidonic acid metabolites described in two GC/MS runs. The detection limit was in the femtomole range. Application of the method to the quantitative profiling of arachidonic acid metabolites in various tissues and incubation media is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962666     DOI: 10.1002/bms.1200141108

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  6 in total

1.  Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation.

Authors:  H C Köfeler; G Fauler; W Windischhofer; H J Leis
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  On the inhibition of prostanoid formation by SK&F 96365, a blocker of receptor-operated calcium entry.

Authors:  H J Leis; D Zach; E Huber; L Ziermann; H Gleispach; W Windischhofer
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

3.  Molecular characterisation of group IVA (cytosolic) phospholipase A2 in murine osteoblastic MC3T3-E1 cells.

Authors:  Hans Jörg Leis; Werner Windischhofer
Journal:  Protein J       Date:  2015-02       Impact factor: 2.371

4.  Differential effects of interleukin-1 alpha and beta on the arachidonic acid cascade in human synovial cells and chondrocytes in culture.

Authors:  I Knott; M Dieu; M Burton; V Lecomte; J Remacle; M Raes
Journal:  Agents Actions       Date:  1993-07

5.  Inhibition of prostanoid formation in intact cells by 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a blocker of Ca(2+)-ATPases.

Authors:  H J Leis; D Zach; E Huber; L Ziermann; H Gleispach; W Windischhofer
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Inhibition of cyclooxygenases 1 and 2 by the phospholipase-blocker, arachidonyl trifluoromethyl ketone.

Authors:  H J Leis; W Windischhofer
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.